Long-term treatment with centrilizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (The ETAC trial) over 18 months

TL Diepgen, - ETAC Study Group, Arnold Oranje

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)278-286
Number of pages9
JournalPediatric Allergy and Immunology
Volume13
Publication statusPublished - 2002

Cite this